Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1179 |  KOD Kodiak Sciences Inc - Common Stock | 94.26 USD | +3.49% | -3.96% | +183.15% | +603.43% | 5.92 B USD | ||
| 1182 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 295.00 USD | +0.59% | -4.08% | +2.42% | +57.65% | 5.88 B USD | ||
| 1248 |  ERAS Erasca, Inc. - Common Stock | 15.46 USD | +9.49% | +4.39% | +0.59% | +538.84% | 5.41 B USD | ||
| 1266 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 81.35 USD | +0.88% | -3.93% | -17.01% | +16.00% | 5.28 B USD | ||
| 1272 |  PTCT PTC Therapeutics, Inc. - Common Stock | 62.56 USD | -1.06% | -3.47% | -6.40% | -5.17% | 5.22 B USD | ||
| 1273 |  COGT Cogent Biosciences, Inc. - Common Stock | 30.08 USD | -0.20% | -6.35% | -14.28% | +91.96% | 5.22 B USD | ||
| 1284 |  SRRK Scholar Rock Holding Corporation - Common Stock | 42.20 USD | 0.00% | -9.71% | -26.38% | +40.57% | 5.14 B USD | ||
| 1317 |  TVTX Travere Therapeutics, Inc. - Common Stock | 52.04 USD | -2.62% | -9.04% | -20.91% | +80.88% | 4.91 B USD | ||
| 1318 |  CRSP CRISPR Therapeutics AG - Common Shares | 50.44 USD | -3.65% | -10.65% | -3.92% | -34.77% | 4.88 B USD | ||
| 1360 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 82.43 USD | -2.89% | -7.43% | -22.15% | +136.66% | 4.61 B USD | ||
| 1364 |  DFTX Definium Therapeutics, Inc. - Common Shares | 34.18 USD | -2.59% | -9.34% | -9.62% | +126.21% | 4.59 B USD | ||
| 1417 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.23 USD | -0.86% | -4.34% | -8.83% | +157.58% | 4.26 B USD | ||
| 1436 |  ADPT Adaptive Biotechnologies Corporation - Common Stock | 26.09 USD | -0.72% | -5.44% | +8.48% | +51.16% | 4.16 B USD | ||
| 1498 |  RLAY Relay Therapeutics, Inc. - Common Stock | 17.41 USD | -3.01% | -6.95% | -4.86% | +152.32% | 3.82 B USD | ||
| 1500 |  TNGX Tango Therapeutics, Inc. - Common Stock | 22.57 USD | +3.39% | -10.04% | -2.55% | +204.59% | 3.81 B USD | ||
| 1510 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.01 USD | -0.99% | +3.48% | -8.93% | +74.48% | 3.73 B USD | ||
| 1517 |  ABCL AbCellera Biologics Inc. - Common Shares | 12.02 USD | -6.31% | -14.75% | +11.40% | +103.38% | 3.69 B USD | ||
| 1549 |  VCYT Veracyte, Inc. - Common Stock | 43.60 USD | +1.02% | -2.98% | +1.89% | +18.16% | 3.51 B USD | ||
| 1550 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 36.16 USD | -0.69% | -7.52% | -38.75% | -11.35% | 3.50 B USD | ||
| 1553 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 36.06 USD | -0.55% | -6.39% | -7.16% | +10.68% | 3.48 B USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |